Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
Clinical trial NCT05273827 · COMPLETED
Trial details
- NCT number
- NCT05273827
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-22
- Primary completion
- 2023-12-20
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.